1h Free Analyst Time
Biotron Ltd (BIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Biotron Ltd (Biotron) is a clinical stage biotechnology company develops novel small molecule antiviral therapeutics for the treatment of infectious diseases such as hepatitis C virus (HCV) and HIV-1. Biotron’s core focus is to design and develop drugs that target a new class of viral proteins (viroporins). The company’s lead drug candidate, BIT225 is in Phase II clinical trials for the treatment of both HIV-1. Biotron also has other preclinical programs targeting infectious diseases such as dengue, Zika and Hepatitis B. It holds patents for drug candidates in various countries including Australia, Canada, China, Europe, Japan, New Zealand, the US and other countries. Biotron is headquartered in Sydney, New South Wales, Australia.Biotron Ltd Key Recent Developments
Nov 18, 2022: Biotron releases R&D Tax IncentiveApr 05, 2022: Biotron : R&D tax incentive
Apr 28, 2021: Report on activities for the quarter ended 31 march 2021
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company- Biotron Ltd - Key Facts
- Biotron Ltd - Key Employees
- Biotron Ltd - Key Employee Biographies
- Biotron Ltd - Major Products and Services
- Biotron Ltd - History
- Biotron Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Biotron Ltd - Business Description
- Biotron Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Biotron Ltd - Strengths
- Biotron Ltd - Weaknesses
- Biotron Ltd - Opportunities
- Biotron Ltd - Threats
- Biotron Ltd - Key Competitors
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
- Biotron Ltd, Recent Deals Summary
- Nov 18, 2022: Biotron releases R&D Tax Incentive
- Apr 05, 2022: Biotron : R&D tax incentive
- Apr 28, 2021: Report on activities for the quarter ended 31 march 2021
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- Biotron Ltd, Key Facts
- Biotron Ltd, Key Employees
- Biotron Ltd, Key Employee Biographies
- Biotron Ltd, Major Products and Services
- Biotron Ltd, History
- Biotron Ltd, Other Locations
- Biotron Ltd, Key Competitors
- Biotron Ltd, Annual Ratios
- Biotron Ltd, Interim Ratios
- Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
- Biotron Ltd, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- Biotron Ltd, Performance Chart (2018 - 2022)
- Biotron Ltd, Ratio Charts
- Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Biotron Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022
Companies Mentioned
A selection of companies mentioned in this report includes:
- Benitec Biopharma Inc
- Viralytics Pty Ltd
- Kazia Therapeutics Ltd
- QRxPharma Ltd
- Immuron Ltd